Scientific Publication on Clinical Studies of VAL001
Respiratorius announces that the high-ranking scientific journal of the American Society of Hematology – Blood Advances, accepted the manuscript "Valproate in Combination with Rituximab and CHOP as First Line Therapy in Diffuse Large B-cell Lymphoma (VALFRID)" for immediate publication.The scientific article summarizes the implementation and results of the study. The key results from the Phase I / IIa stuies are presented briefly: · • Potential synergistic effect with Rituximab as VAL001 increases the levels of the surface protein CD20. · • Overall Survival Analysis for